AgomiR-31-5p ameliorates diabetes-associated cognitive impairment by suppressing hippocampal neuroinflammation via RAGE-associated signaling.
Diabetes-associated cognitive impairment is closely linked to hippocampal neuroinflammation, but effective treatments remain limited. This study investigated the protective effects of agomiR-31-5p against cognitive dysfunction and neuroinflammatory injury in db/db mice. Male db/db mice received agomiR-31-5p via tail-ve...